NOBIVAC® INTRA-TRAC®₃ EFFICACY

PROMOTES A STRONGER IGA RESPONSE THAN SUBCUTANEOUS VACCINATION^16,17

• IgA on mucosal surfaces appears to be more important than systemic responses when it comes to protecting against respiratory pathogens ^18,19
  • Prevents microbes from adhering to mucosal surfaces of the nose and throat
  • Helps clear microbes trapped in mucus at the point of entry
• Eliminated Bordetella shedding in controlled challenge 9 weeks after vaccination¹⁶
• Significantly reduced cough scores and days of coughing¹⁶